Wintest
6721
Showcase
3909
Beauty Kadan Holdings
3041
Cybozu
4776
KODAMA CHEMICAL INDUSTRY
4222
(Q1)Jun 30, 2024 | (FY)Mar 31, 2024 | (Q4)Mar 31, 2024 | (Q3)Dec 31, 2023 | (Q2)Sep 30, 2023 | (Q1)Jun 30, 2023 | (FY)Mar 31, 2023 | (Q4)Mar 31, 2023 | (Q3)Dec 31, 2022 | (Q2)Sep 30, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Total revenue | -13.39%13B | -21.99%55.8B | -23.65%13.87B | -33.89%13.16B | -22.54%13.76B | -4.36%15.01B | 25.29%71.53B | 16.96%18.17B | 30.85%19.91B | 22.99%17.76B |
Cost of revenue | -7.06%9.59B | -12.14%40.19B | -10.93%10.56B | -24.90%9.43B | -13.63%9.89B | 4.35%10.32B | 31.96%45.74B | 24.26%11.85B | 40.54%12.55B | 23.87%11.45B |
Gross profit | -27.32%3.41B | -39.48%15.61B | -47.54%3.31B | -49.24%3.73B | -38.70%3.87B | -19.19%4.69B | 14.98%25.79B | 5.34%6.31B | 17.08%7.36B | 21.41%6.31B |
Operating expense | -3.47%3.65B | -0.51%15.48B | -7.35%3.85B | 0.34%3.94B | 2.92%3.91B | 2.75%3.78B | 13.70%15.56B | 10.29%4.15B | 19.24%3.93B | 9.90%3.8B |
Operating profit | -126.12%-238.25M | -98.78%124.58M | -124.89%-537.29M | -106.15%-210.8M | -101.56%-39.3M | -57.12%911.97M | 16.99%10.22B | -3.03%2.16B | 14.70%3.43B | 44.24%2.51B |
Net non-operating interest income (expenses) | 201.24%30.85M | 47.24%-80.21M | 75.29%-9.2M | 48.41%-21.45M | 49.29%-19.09M | 14.34%-30.47M | -21.43%-152.03M | -7.45%-37.24M | -13.10%-41.58M | -21.23%-37.65M |
Non-operating interest income | 530.99%81.66M | 547.82%96.86M | 395.54%37.81M | 377.87%23.28M | 1,274.59%22.83M | 1,538.23%12.94M | 15.19%14.95M | 226.17%7.63M | 498.40%4.87M | -65.27%1.66M |
Non-operating interest expense | 17.06%50.82M | 6.04%177.07M | 4.77%47.01M | -3.71%44.73M | 6.65%41.92M | 19.40%43.41M | 20.84%166.98M | 21.28%44.86M | 23.61%46.45M | 9.69%39.31M |
Net investment income | -83.19%29.41M | -25.63%404.8M | 50.38%285.88M | -30.65%-177.54M | -57.55%121.58M | -14.13%174.89M | 147.41%544.3M | 26.70%190.1M | -597.89%-135.89M | 167.29%286.42M |
Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
Gain(Loss) on derecognition of available-for-sale financial assets | ||||||||||
Income from associates and other participating interests | 46.25%-5.85M | -4,737.34%-41.84M | 71.33%-3M | -391.56%-14.05M | -828.44%-13.91M | -273.21%-10.88M | 83.99%-865K | -597.34%-10.47M | 224.13%4.82M | 54.77%-1.5M |
Special income (charges) | -216.61%-2.87M | -4,903.70%-28.18B | -137,636.37%-28.17B | -226.88%-11.1M | 97.86%-682K | 100.48%2.46M | -376.23%-563.11M | 64.88%-20.45M | 64.68%-3.4M | -7.13%-31.84M |
Less:Other special charges | 216.61%2.87M | -96.96%17.1M | -62.00%7.77M | 226.88%11.1M | -97.86%682K | -100.48%-2.46M | 786.51%563.11M | 482.29%20.45M | -64.68%3.4M | 7.13%31.84M |
Less:Write off | ---- | --28.16B | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- |
Other non-operating income (expenses) | -24.90%49.11M | 15.18%163.01M | -18.33%68.03M | -86.71%26.01M | 102.67%3.57M | 1,770.77%65.39M | -49.30%141.52M | 547.84%83.31M | -8.07%195.64M | -413.97%-133.51M |
Income before tax | -112.36%-137.6M | -370.79%-27.61B | -1,299.76%-28.36B | -111.87%-408.94M | -97.99%52.17M | -37.79%1.11B | 13.13%10.19B | 1.90%2.36B | 8.46%3.44B | 41.97%2.6B |
Income tax | -83.46%145.73M | -207.71%-2.8B | -6,493.70%-3.96B | -71.92%306.11M | -103.33%-28.65M | 50.50%881.15M | 13.26%2.6B | -58.28%61.9M | 18.34%1.09B | 32.39%861.25M |
Net income | -222.02%-283.33M | -426.58%-24.81B | -1,160.11%-24.4B | -130.37%-715.06M | -95.34%80.82M | -80.72%232.2M | 13.08%7.6B | 6.01%2.3B | 4.42%2.35B | 47.26%1.73B |
Net income continuous operations | -222.02%-283.33M | -426.58%-24.81B | -1,160.11%-24.4B | -130.37%-715.06M | -95.34%80.82M | -80.72%232.2M | 13.08%7.6B | 6.01%2.3B | 4.42%2.35B | 47.26%1.73B |
Noncontrolling interests | 0 | 0 | 0 | 0 | 0 | 0 | ||||
Net income attributable to the company | -222.02%-283.33M | -426.58%-24.81B | -1,160.11%-24.4B | -130.37%-715.06M | -95.34%80.82M | -80.72%232.2M | 14.33%7.6B | 6.01%2.3B | 4.49%2.35B | 58.16%1.73B |
Preferred stock dividends | ||||||||||
Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Net income attributable to common stockholders | -222.02%-283.33M | -426.58%-24.81B | -1,160.11%-24.4B | -130.37%-715.06M | -95.34%80.82M | -80.72%232.2M | 14.33%7.6B | 6.01%2.3B | 4.49%2.35B | 58.16%1.73B |
Gross dividend payment | ||||||||||
Basic earnings per share | -222.13%-2.98 | -427.60%-261 | -1,161.03%-256.77 | -130.41%-7.52 | -95.33%0.85 | -80.56%2.44 | 15.43%79.67 | 7.27%24.2 | 5.64%24.73 | 59.56%18.19 |
Diluted earnings per share | -222.13%-2.98 | -427.60%-261 | -1,161.81%-256.9583 | -130.42%-7.5225 | -95.33%0.85 | -80.56%2.44 | 15.43%79.67 | 7.28%24.2 | 5.64%24.73 | 59.65%18.19 |
Dividend per share | 0 | -28.57%20 | -41.18%10 | 0 | -9.09%10 | 0 | 33.33%28 | 54.55%17 | 0 | 10.00%11 |
Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |